Regulatory Updates

FDA, EMA, TGA and global regulatory developments

#4795 ×

Regulatory Updates

Sep 23, 2026•1 min read

FDA Discontinues Hydroxyzine Hydrochloride Injection (ANDA 086822)

The FDA has listed Hydroxyzine Hydrochloride injectable (product 001) from sponsor SoloPak as discontinued under ANDA 086822.